Clinical-stage synthetic-peptide immunotherapeutics for cancer and viral infections
| Date | Round | Amount |
|---|---|---|
| Jul 2021 | Funding round Dutch immunotherapy company ISA Pharmaceuticals raised EUR26M from new investor Invest-NL and existing investor Regeneron. | $26M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.